LEARN MORE >
Investors 1
| Date | Name | Website |
| 13.10.2022 | IMO Ventur... | imo.vc/ |
Mentions in press and media 1
| Date | Title | Description |
| 05.08.2024 | META Pharmaceuticals announces FDA Grants Rare Pediatric Disease Designation to META-001-PH for the Treatment of Primary Hyperoxaluria | HONG KONG, Aug. 5, 2024 /PRNewswire/ -- META Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to its investigational new drug META-001-PH for the treatment... |